Pharmacogenomics (PGx), the study of gene variants associated with drug metabolism, has provided new insights into how a person’s genetic profile can affect their response to treatment. Modern medicine is slowly shifting from a “one-size-fits-all” approach to a more personalized approach with therapies tailored to a particular patient type or population.
Personalized medicine, based on pharmacogenomic testing, now enables clinicians to make informed therapeutic decisions for improved medical management. This means that you can design treatments specifically for each individual, based on their genetic makeup. As a result, patients can experience better outcomes and fewer side effects.